AmorePacific's AmorePacific Ventures corporate venture fund gained an option of first negotiation to license exclusive rights to two of Brickell's compounds in the Republic of Korea

Brickell Biotech Inc.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

AmorePacific Corp.

South Korea / Other

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced